Description

Cagrilintide is synthesized via solid-phase peptide synthesis (SPPS) and purified using high-performance liquid chromatography (HPLC) to achieve a minimum purity of ≥99%, verified through independent analytical testing. This compound is supplied strictly for in vitro laboratory and scientific research use only — it is not approved, labeled, or intended for human or veterinary administration, consumption, or therapeutic use of any kind. Each unit is lyophilized to preserve stability and should be stored at -20°C (or per accompanying technical documentation) until reconstitution by qualified laboratory personnel using appropriate aseptic technique, in support of metabolic pathway and receptor interaction studies. Handling, reconstitution, and disposal must be performed in accordance with standard laboratory safety protocols and institutional biosafety guidelines. By purchasing this product, the buyer confirms they are a qualified researcher or institution acquiring this material solely for legitimate scientific research purposes.